I can’t reliably pull very latest (May 2026) headlines in this chat right now, but I can summarize the most recent research directions that are currently driving news/updates about hepcidin as an antimicrobial peptide—and point you to a couple of credible, up-to-date review articles I found earlier.
What’s been “in the news” (research-wise) for hepcidin AMPs
- Hepcidin-derived peptides vs. bacteria: Recent work (and reviews) continues to focus on using hepcidin (or hepcidin fragments/variants) as antimicrobial agents, including reports that different hepcidin variants can show different killing speed and effectiveness depending on conditions like pH.[1]
- Dual role: antimicrobial + iron regulation: Hepcidin is widely discussed as part of innate immunity because it both affects iron availability (which microbes need) and has direct antimicrobial activity, making it attractive for “host-directed” or combination therapies.[3][5]
- Therapeutic potential—but practical hurdles: Reviews emphasize challenges such as synthesis/disulfide-bond complexity, partial inhibition in body fluids, and the need for optimization before clinical use.[1]
Specific examples from recent literature
- A 2015 review discusses antimicrobial properties of various hepcidin/prohepcidin-related peptides and notes experimental findings like pH-dependent activity changes and differences between peptide variants.[1]
- A 2021 Frontiers review discusses using hepcidins (hamp1/hamp2 in fish models) to prevent or treat bacterial infections and iron disorders, including mortality reduction with one peptide variant in an infection model.[2][3]
If you want, I can narrow to the “latest news” you care about
Tell me which you mean by “latest”:
- Clinical news (trials in humans)
- Lab research (new papers/preprints)
- Biotech/IP (company pipelines)
- A specific organism (human hepcidin vs. fish hepcidins)
And if you share any keywords you’ve seen (e.g., “hamp2”, “antimicrobial fragment”, “iron homeostasis”), I’ll tailor the results to that exact angle.
Sources
The current treatments applied in aquaculture to limit disease dissemination are mostly based on the use of antibiotics, either as prophylactic or therapeuti...
www.frontiersin.orgHepcidin is a small peptide composed of signal peptide, propeptide, and the bioactive mature peptide from N terminal to C terminal. Mature hepcidin is an antibacterial peptide and iron regulator with eight highly conserved cysteines forming four ...
pmc.ncbi.nlm.nih.govThe increasing frequency of multi-drug resistant microorganisms has driven research into alternative therapeutic strategies. In this respect, natural antimicrobial peptides (AMPs) hold much promise as candidates for the development of novel ...
pmc.ncbi.nlm.nih.govThe current treatments applied in aquaculture to limit disease dissemination are mostly based on the use of antibiotics, either as prophylactic or therapeutic agents, with vaccines being available for a limited number of fish species and pathogens. Antimicrobial peptides are considered as promising …
pubmed.ncbi.nlm.nih.govHepcidin is a small peptide composed of signal peptide, propeptide, and the bioactive mature peptide from N terminal to C terminal. Mature hepcidin is an ant...
www.frontiersin.orgBackground/Aims Hepcidin (gene name HAMP), an IL-6-inducible acute phase peptide with antimicrobial properties, is the key negative regulator of iron metabolism. Liver is the primary source of HAMP synthesis, but it is also produced by other tissues such as kidney or heart and is found in body fluids such as urine or cerebrospinal fluid. While the role of hepcidin in biliary system is unknown, a recent study demonstrated that conditional gp130-knockout mice display diminished hepcidin levels...
journals.plos.orgAntimicrobial peptides (AMPs) are involved in the innate immunity of human body to battle microbial pathogens. In addition, human AMPs play also an im…
www.sciencedirect.comThe current treatments applied in aquaculture to limit disease dissemination are mostly based on the use of antibiotics, either as prophylactic or therapeutic agents, with vaccines being available for a limited number of fish species and pathogens. ...
pmc.ncbi.nlm.nih.gov